CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance at the beginning of the period (in shares) at Jul. 03, 2021		228.3
Balance at the beginning of the period at Jul. 03, 2021	$ 763.9	$ 0.2	$ 70,183.2	$ (69,322.3)	$ (97.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(1.0)			(1.0)
Other comprehensive income	(24.1)				(24.1)
Shares issued under employee stock plans, net of tax (in shares)		2.0
Shares issued under employee stock plans, net of tax	(4.5)		(4.5)
Stock-based compensation	39.4		39.4
Repurchase of common stock (in shares)		(12.7)
Repurchase of common stock	(206.6)			(206.6)
Convertible note settlement (in shares)		10.6
Convertible note settlement	142.8		142.8
Balance at the end of the period (in shares) at Apr. 02, 2022		228.2
Balance at the end of the period at Apr. 02, 2022	709.9	$ 0.2	70,360.9	(69,529.9)	(121.3)
Balance at the beginning of the period (in shares) at Jan. 01, 2022		232.5
Balance at the beginning of the period at Jan. 01, 2022	774.8	$ 0.2	70,354.3	(69,470.4)	(109.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	19.2			19.2
Other comprehensive income	(12.0)				(12.0)
Shares issued under employee stock plans, net of tax (in shares)		0.4
Shares issued under employee stock plans, net of tax	2.7		2.7
Stock-based compensation	12.8		12.8
Repurchase of common stock (in shares)		(4.7)
Repurchase of common stock	(78.7)			(78.7)
Convertible note settlement	(8.9)		(8.9)
Balance at the end of the period (in shares) at Apr. 02, 2022		228.2
Balance at the end of the period at Apr. 02, 2022	709.9	$ 0.2	70,360.9	(69,529.9)	(121.3)
Balance at the beginning of the period (in shares) at Jul. 02, 2022		226.4
Balance at the beginning of the period at Jul. 02, 2022	671.7	$ 0.2	70,370.2	(69,542.3)	(156.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	25.6			25.6
Other comprehensive income	13.5				13.5
Shares issued under employee stock plans, net of tax (in shares)		2.3
Shares issued under employee stock plans, net of tax	(3.5)		(3.5)
Stock-based compensation	38.8		38.8
Repurchase of common stock (in shares)		(6.3)
Repurchase of common stock	(73.9)			(73.9)
Convertible note settlement	10.1		10.1
Balance at the end of the period (in shares) at Apr. 01, 2023		222.4
Balance at the end of the period at Apr. 01, 2023	682.3	$ 0.2	70,415.6	(69,590.6)	(142.9)
Balance at the beginning of the period (in shares) at Dec. 31, 2022		224.8
Balance at the beginning of the period at Dec. 31, 2022	687.8	$ 0.2	70,388.8	(69,545.2)	(156.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(15.4)			(15.4)
Other comprehensive income	13.1				13.1
Shares issued under employee stock plans, net of tax (in shares)		0.4
Shares issued under employee stock plans, net of tax	4.0		4.0
Stock-based compensation	12.7		12.7
Repurchase of common stock (in shares)		(2.8)
Repurchase of common stock	(30.0)			(30.0)
Convertible note settlement	10.1		10.1
Balance at the end of the period (in shares) at Apr. 01, 2023		222.4
Balance at the end of the period at Apr. 01, 2023	$ 682.3	$ 0.2	$ 70,415.6	$ (69,590.6)	$ (142.9)